HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kwon, H. Articles by Yoon, J.-W. Search for Related Content PubMed PubMed Citation Articles by Kwon, H. Articles by Yoon, J.-W.

Role of CTLA-4 in the Activation of Single- and Double-Positive Thymocytes¹

Hyokjoon Kwon^*, Hee-Sook Jun^2,*,, Lee-Yong Khil^* and Ji-Won Yoon^2,*,

^* Julia McFarlane Diabetes Research Center, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Rosalind Franklin Diabetes Center, Chicago Medical School, North Chicago, IL 60064

CTLA-4, a homologue of CD28, is a negative regulator of T cell activation in the periphery and is transiently expressed on the cell surface after T cell activation. However, the role of CTLA-4 in T cell activation in the thymus is not clear. This investigation was initiated to determine the role of CTLA-4 in the activation of CD4⁺CD8⁺ double-positive (DP) and CD4⁺CD8^– and CD4^–CD8⁺ single-positive (SP) thymocytes using fetal thymic organ cultures (FTOC) of MHC class II-restricted, OVA_323–339-restricted TCR transgenic mice (DO11.10). We found that treatment of the FTOC with anti-CTLA-4-blocking Ab during activation with OVA_323–339 increased the proportion and number of DP thymocytes, but decreased the proportion and number of SP thymocytes compared with OVA_323–339-stimulated FTOC without anti-CTLA-4 Ab treatment. In addition, anti-CTLA-4 Ab treatment inhibited OVA_323–339-induced expression of the early activation marker, CD69, in DP thymocytes, but increased CD69 in SP thymocytes. Similarly, CTLA-4 blockage decreased phosphorylation of ERK in DP thymocytes by Ag-specific TCR engagement, but increased phosphorylation of ERK in SP thymocytes. CTLA-4 blockage inhibited deletion of DP thymocytes treated with a high dose of OVA_323–339, whereas CTLA-4 blockage did not inhibit deletion of DP thymocytes treated with a low dose of OVA_323–339. We conclude that CTLA-4 positively regulates the activation of DP thymocytes, resulting in their deletion, whereas blocking CTLA-4 suppresses the activation of DP thymocytes, leading to inhibition of DP thymocyte deletion. In contrast, CTLA-4 negatively regulates the activation of SP thymocytes.

This article has been cited by other articles:

				W. A. Teft and J. Madrenas Molecular Determinants of Inverse Agonist Activity of Biologicals Targeting CTLA-4 J. Immunol., September 15, 2007; 179(6): 3631 - 3637. [Abstract] [Full Text] [PDF]

				H.-P. Raue and M. K. Slifka Pivotal Advance: CTLA-4+ T cells exhibit normal antiviral functions during acute viral infection J. Leukoc. Biol., May 1, 2007; 81(5): 1165 - 1175. [Abstract] [Full Text] [PDF]

				S. Mukherjee, A. Ahmed, S. Malu, and D. Nandi Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2 J. Leukoc. Biol., July 1, 2006; 80(1): 66 - 74. [Abstract] [Full Text] [PDF]

				J. K. Yoo, H. Kwon, L.-Y. Khil, L. Zhang, H.-S. Jun, and J.-W. Yoon IL-18 Induces Monocyte Chemotactic Protein-1 Production in Macrophages through the Phosphatidylinositol 3-Kinase/Akt and MEK/ERK1/2 Pathways J. Immunol., December 15, 2005; 175(12): 8280 - 8286. [Abstract] [Full Text] [PDF]